This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New 'disappearing Stent' Restores Blood Flow To Hearts

Scottsdale Healthcare is first in region to implant investigational device in patients with clogged arteries

SCOTTSDALE, Ariz., March 4, 2013 /PRNewswire-USNewswire/ -- A dissolvable stent that opens clogged arteries in the heart has researchers at Scottsdale Healthcare encouraged that it may become a game changing technology for treating the symptoms of coronary artery disease (CAD), the most common type of heart disease.

Interventional cardiologist David Rizik, MD is the first physician in the western U.S. to successfully implant the investigational device into a heart patient as part of a new clinical trial enrolling patients at Scottsdale Healthcare.

The Absorb Bioresorbable Vascular Scaffold (BVS), made by healthcare company Abbott, is a small mesh tube made of polylactide, a material that is commonly used in medical implants such as dissolvable sutures.  Absorb is coated with a medication which reduces inflammation and tissue growth to help prevent renarrowing of the artery.

The scaffold restores blood flow and provides support to the vessel until the artery can stay open on its own. It dissolves over time, potentially allowing the vessel to resume more natural function and movement.

The clinical trial is evaluating potential benefits of Absorb in comparison to the leading metallic drug eluting stent in patients with CAD, the most common cause of death for men and women in the United States. Absorb is authorized for sale in CE Mark countries and is available in Europe, the Middle East, parts of Latin America, and parts of Asia Pacific, including India, Hong Kong, Malaysia and New Zealand.

"The bioresorbable scaffold represents a potential game changing technology for our patients with coronary artery disease," said Dr. Rizik. "The idea of moving away from permanent metal implants to literally disappearing implants is a quantum leap forward for our heart patients at Scottsdale Healthcare. The cardiology team of physicians, nursing staff and clinicians are extremely pleased to participate in the trial of this latest advancement to our community."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,121.72 -10.14 -0.06%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,811.92 -26.7230 -0.55%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs